World Retail Pharma Sales To May 1994 Rise 3%

7 August 1994

The world market for pharmaceutical products purchased through retail pharmacies rose 3% to $47.78 billion in the five months from January to May 1994, compared with the like, year-earlier period, according to figures from IMS International.

Sales in North America as a whole rose 6% to $21 billion, which breaks down as a 7% increase to $19.69 billion for the USA and a 2% rise to $1.38 billion for Canada. In Japan, the market was flat in terms of local currency, although by dollar value it rose from $7.7 billion to $8.45 billion.

Sales in Europe's leading seven markets fell from $19.1 billion in January-May 1993 to $18.26 billion in the same period this year, although in local currency terms they advanced 2%. Germany reported a 6% rise to $5.23 billion, while sales in France were flat in local currency terms, falling from $5.18 billion to $4.92 billion when expressed in dollars. The Italian market fell sharply by 7% from $3.59 billion to $3.08 billion.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight